期刊名称：NEUROBIOLOGY OF DISEASE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Neurobiology of Disease
|
Neurobiology of Disease is a major International journal at the interface between basic and clinical neuroscience. The journal provides a forum for the publication of top quality research papers on: molecular and cellular definitions of disease mechanisms, the neural systems and underpinning behavioral disorders, the genetics of inherited neurological and psychiatric diseases, nervous system aging, and findings relevant to the development of new therapies. |
|
Instructions to Authors
Neurobiology of Disease is an international journal at the interface between basic and clinical neuroscience. The journal provides a forum for the publication of top-quality research papers on molecular and cellular definitions of disease mechanisms, the neural systems underpinning behavioral disorders of higher cortical function, the genetics of inherited neurological and psychiatric diseases, aging and the nervous system, and findings relevant to the development of new therapeutics. Timely reviews in these areas will be considered.
Submission of Manuscripts. Manuscripts for research papers and reviews must be written in English and should be submitted in quadruplicate (one original and three photocopies). An electronic form of the manuscript must also be submitted at initial submission and each time a version is submitted, to:
NBD Editorial Office
525 B Street, Suite 1900
San Diego, CA 92101-4495, USA
Tel: (619) 699-6808
Fax: (619) 699-6855
e-mail: nbd@elsevier.com
Alternatively, the manuscript can be submitted using the Elsevier online submission tool as described below under Electronic Submission.
Electronic Submission. Neurobiology of Disease manuscripts may be submitted using the Elsevier electronic submission tool, located on the Elsevier Author Gateway. To use this submission route, please go to the Web site and upload your article and its associated artwork. A PDF is generated and the review process is carried out using that PDF. All correspondence between editor and author is performed by e-mail, and paper copies are not required at the original submission stage. To submit your paper on line, please click here.
Submission as an e-mail attachment is also acceptable provided that all files are included in a single archive the size of which does not exceed 2 megabytes (nbd@elsevier.com). Larger files (e.g., those with large images should be submitted via the FTP site (ftp.elsevier.com with username anon and password essd4acc). Hard-copy printouts of the manuscript and art that exactly match the electronic file must then be supplied. The manuscript will be edited according to the style of the journal, and authors must read the proofs carefully. Complete instructions for electronic artwork submission can be found on the Author Gateway, accessible through the journal home page(http://www.elsevier.com/locate/ynbdi).
Cover Letter. A cover letter should accompany the submission, which should include the names of at least four suitable referees for their manuscripts on submission, giving telephone and fax numbers and e-mail addresses, as well as postal addresses. Review papers need to be clearly identified as such in the cover letter.
There are no submission fees or page charges. Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published or is under consideration for publication elsewhere and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out. Papers in press, or submitted elsewhere, that are relevant to the evaluation of the submitted manuscripts should be provided (three copies).
Copyright and Permissions. Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright, see http://authors.elsevier.com). This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided after acceptance.
If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier Global Rights Department, P.O. Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com.
Preparation of Manuscript. Most recommendations of the Council of Biology Editors should be followed; consult the CBE Style Manual, 6th ed. (Council of Biology Editors, 9650 Rockville Pike, Bethesda, MD 20814). It is important to differentiate between genes and proteins. All gene names and loci should be typed italic; proteins should be typed roman. Nonstandard abbreviations should be defined at their initial appearance.
Manuscripts should be double-spaced throughout on one side of 8.5 x 11-inch or A4 white paper; pages should be numbered consecutively and organized as follows:
The Title Page (p. 1) should contain the article type (review, regular article), article title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript correspondence (including e-mail address and telephone and fax numbers).
The Abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in less than 150 words. After the abstract a list of up to 10 keywords that will be useful for indexing and searching should be included.
The Introduction should be as concise as possible, without subheadings.
Materials and methods should be sufficiently detailed to enable the experiments to be reproduced.
Results and Discussion may be combined and may be organized into subheadings.
Acknowledgments should be brief and should precede the references.
References should be cited in the text by name and date. Only articles that have been published or are in press should be included in the references. Unpublished results or personal communications should be cited as such in the text. Please note the following examples:
Abbot, F., Peele, S.T., 2000. Behavior of transgenic mice expressing presenilin 1. Neurobiol. Dis. 12, 15-31.
Stutzman, J., 1994 Neurodegenerative Diseases. Academic Press, San Diego.
Tracey, D.J., 1995 Ascending and descending pathways in the spinal cord. In: Paxinos, G. (Ed.), Rat Nervous System, 2nd ed.Academic Press, pp. 67-75.
GenBank/DNA sequence linking. Authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalized (see example below). This combination of letters and format will enable the typesetter to recognize the relevant texts as accession numbers and add the required links to GenBank sequences.
Example: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link.
In the final version of the printed article, the accession number text will not appear bold or underlined. In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article.
Figures should be in a finished form suitable for publication. Number figures consecutively with Arabic numerals, and indicate the top and the authors on the back of each figure. Lettering on drawings should be professional quality or generated by high-resolution computer graphics and must be large enough to withstand appropriate reduction for publication. Please visit our Web site at http://authors.elsevier.com/artwork for detailed instructions on preparing electronic artwork.
Color Figures. One color plate will be published free of charge in each article, provided that color is deemed scientifically necessary by the reviewers and the Editorial Board. Additional color figures will be charged to the author. Mounted color figures must be submitted on paper or flexible board due to the nature of the reproduction process.
Color figures for exclusive use as cover illustrations may be submitted by authors who are also submitting a manuscript for consideration. These figures do not need to relate to the manuscript being submitted but should relate to the larger scope and focus of Neurobiology of Disease.
Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title typed directly above and with essential footnotes below. Authors should submit complex tables as camera-ready copy.
Proofs will be sent to the corresponding author. To avoid delay in publication, only necessary changes should be made, and proofs should be returned promptly. Authors will be charged for alterations that exceed 10% of the total cost of composition.
Distribution of Material. Authors who publish a research article in Neurobiology of Disease must be prepared to freely distribute to academic researchers for their own use any cell lines, DNA clones, monoclonal antibodies, or genetically engineered mice described in the article. Nucleic acid and protein sequences, as well as crystallographic coordinates, must be deposited in the appropriate databases.
Editorial Board
-
- Editors in Chief
- J. Mallet, LGN-CNRS, Batiment CERVI, Hopital de la Pitie Salpetriere, 83 Boulevard de l'Hopital, F 75103 Paris, France Tel: 011 33 142 177537, Fax: 011 33 142 177575, Email: suorsoni@infobiogen.fr
W.C. Mobley, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, 1201 Welch Road, P205, Stanford, CA 94305-5235 Tel: 650-723-6424, Fax: 650-725-7459, Email: ksn@stanford.edu
- Review Editor
- R.S. Zukin, Albert Einstein College of Medicine, Department Of Neuroscience, Kennedy Building, 1410 Pelha Pkway, South Room 603, Bronx, New York, NY 10461, USA Tel: 001 718 430 2160, Fax: 001 718 430 8932, Email: zukin@aecom.yu.edu
- Editorial Board
- P. Aebischer
Y. Agid
A. Aguayo
H. Akil
R.L. Barchi
A.I. Basbaum
M.F. Beal
K. Beyreuther
A. Bjorklund
I.B. Black
F. Bloom
J. Collinge
E. Costa
C.W. Cotman
J.T. Coyle
R.G. Dacey Jr
V.L. Dawson
M.A. Dichter
E.L. Feldman
H.L. Fields
G.D. Fischbach
K.H. Fischbeck
R.S.J. Frackowiak
F.H. Gage
R.M. Gardiner
S. Gilman
A. Goate
J. Gusella
D.H. Gutmann
S.F. Heinemann
D.M. Holtzman
S.E. Hyman
E.M. Johnson Jr
S.A. Lipton
R.L. MacDonald
J.L. Mandel
J.C. Mazziotta
P. McGuffin
R.D.G. McKay
M.A. Moskowitz
A. Munnich
S. Nakanishi
C.B. Nemeroff
D.L. Price
S.B. Prusiner
M.C. Raff
A.D. Roses
C.A. Ross
S.M. Rothman
M.E. Schwab
P.H. Seeburg
D.J. Selkoe
E.M. Shooter
B.K. Siesjo
S.S. Sisodia
S.H. Snyder
H. Soreq
L. Steinman
A.J. Tobin
J.Q. Trojanowski
M.H. Tuszynski
C.L. Van Broeckhoven
S.G. Waxman
A.B. Young
M.J. Zigmond
C.F. Zorumski
|
